SGLT2 inhibitors for diabetes SGLT2
sglt2 inhibitors called gliflozins. lead reduction in blood glucose levels. therefore, sglt2 inhibitors have potential use in treatment of type ii diabetes. gliflozins enhance glycemic control reduce body weight , systolic , diastolic blood pressure. gliflozins canagliflozin, dapagliflozin, , empagliflozin may lead euglycemic ketoacidosis. other side effects of gliflozins include increased risk of (generally mild) genital infections, such candidal vulvovaginitis.
Comments
Post a Comment